FTC Sues Amare Global, Accusing Supplement Seller of False Mental‑Health Claims for Children and Deceptive Earnings Promises

The Federal Trade Commission sued supplement seller Amare Global Holdings Inc. and three individuals on Tuesday, alleging the multilevel marketing company falsely promoted products for children and adults as able to treat depression, anxiety and ADHD, while also misleading recruits about how much money they could make selling them.

In a civil complaint filed in the U.S. District Court for the Central District of California, the FTC said Amare and its sellers marketed products including Happy Juice, the Happy Juice Product Pack, Kids Mood+ and Kids Happy Juice through Instagram, TikTok, YouTube and Facebook. The case stands out not only because the alleged claims involved children’s mental health, but also because two of the individual defendants were already subject to prior FTC orders restricting false, misleading or unsubstantiated claims.

According to the complaint, Amare and thousands of its “brand partners” claimed the supplements could lower, reduce or regulate cortisol, and raise, increase or normalize serotonin, dopamine and GABA. The FTC also alleged the company and its sellers claimed the products could cure, treat or mitigate depression, anxiety and ADHD in children and adults. The agency said those claims were false, misleading and not backed by adequate substantiation.

The complaint also accuses Amare of using deceptive earnings claims to recruit sellers into its multilevel marketing program. According to the FTC, the company represented that participants could earn set amounts such as $500 a month, or supplement or replace their income, even without prior MLM sales experience or a large social media following. But the complaint said Amare’s own income disclosure statement, available on its website through at least April 2026, showed that a “typical brand partner” earned about $25 per month before expenses. From January 2021 through December 2024, only a small fraction of brand partners made $500 in a month, according to the complaint.

“Amare’s claims were not only deceptive but dangerous since it was aware that some brand partners were taking advantage of parents looking for products to help their children, who suffer from serious conditions like depression and anxiety and need proven treatments,” Christopher Mufarrige, director of the FTC’s Bureau of Consumer Protection, said in a statement. “Companies must make truthful marketing claims and abide by FTC orders, and those that fail to do so will be held accountable by the FTC.”

Amare, founded in 2016, sells supplements and brands itself as “The Mental Wellness Company.” The FTC named David Chung, Amare’s current CEO and majority shareholder, as a defendant along with Shawn Talbott, the company’s former chief science officer, and Patrick Hintze, identified in the complaint as a founding brand partner.

The prior FTC orders are a key part of the case. The agency said Talbott has been under an FTC order since a 2005 matter involving Window Rock Enterprises, while Hintze has been under an FTC order since a 2013 matter involving Green Foot Global, also known as EnviroTabs. In the new lawsuit, the FTC alleges both men were already barred from making false, misleading or unsubstantiated claims.

The FTC said it sued under the FTC Act. The commission vote authorizing the complaint was 2-0. The case, No. 2:26-cv-05900, was filed in federal court in Los Angeles. The agency is seeking a permanent injunction and other relief. Amare did not immediately respond publicly to the FTC action.